Despite the above limitations, this study still demonstrated that the combination of PD‐(L)1 inhibitor and chemotherapy as first‐line treatment could improve the efficacy and prognosis of patients with ES‐SCLC. Here, CD274 is linked to small cell lung carcinoma.